|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12...1011121314151617181920...3233» |
- Enrollment open: Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders (clinicaltrials.gov) - Jun 8, 2014
P=N/A, N=15, Recruiting, Sponsor: Karolinska Institutet
Not yet recruiting --> Recruiting
- Trial primary completion date, MRI: Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=240, Recruiting, Sponsor: University of California, Los Angeles
Not yet recruiting --> Recruiting Trial primary completion date: Aug 2013 --> Jun 2014
- || escitalopram / Generic mfg.
New P3 trial: SSRI Study for Functional Dyspepsia (SS) (clinicaltrials.gov) - Jun 1, 2014
P3, N=72, Recruiting, Sponsor: Chinese University of Hong Kong
- ||| relenopride (YKP-GI) / SK Bio
Enrollment closed: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation (clinicaltrials.gov) - Jun 1, 2014
P2, N=320, Active, not recruiting, Sponsor: SK Life Science
Trial primary completion date: Aug 2013 --> Jun 2014 Recruiting --> Active, not recruiting
- Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma, Sancuso (granisetron) / Solasia
Trial primary completion date: Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=40, Recruiting, Sponsor: University of Southern California
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Sep 2015
- Clinical: Screening for Fabry Disease in a Pediatric Population at Risk (clinicaltrials.gov) - May 29, 2014
P=N/A, N=2000, Recruiting, Sponsor: University Hospital Heidelberg
- morphine sulphate / Generic mfg.
Clinical: AcuMoPE: Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED (clinicaltrials.gov) - May 29, 2014
P0, N=100, Recruiting, Sponsor: University of Monastir
- mizagliflozin (VGX-3235) / Vogenx
Enrollment closed: A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation (clinicaltrials.gov) - May 28, 2014
P2, N=0, Active, not recruiting, Sponsor: Kissei Pharmaceutical Co., Ltd.
Trial primary completion date: Sep 2014 --> Sep 2015 Recruiting --> Active, not recruiting
- mizagliflozin (VGX-3235) / Vogenx
Enrollment closed: A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation (clinicaltrials.gov) - May 28, 2014
P2, N=0, Active, not recruiting, Sponsor: Kissei Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Trial primary completion date: DEFLECT-1: Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (clinicaltrials.gov) - May 27, 2014
P3, N=600, Recruiting, Sponsor: Optimer Pharmaceuticals
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2014 --> Mar 2015
- ||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Trial completion date: DEFLECT-1: Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (clinicaltrials.gov) - May 27, 2014
P3, N=600, Recruiting, Sponsor: Optimer Pharmaceuticals
Trial primary completion date: Jan 2014 --> Mar 2015 Trial completion date: Jan 2014 --> Mar 2015
- ||||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Enrollment change: DEFLECT-1: Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (clinicaltrials.gov) - May 27, 2014
P3, N=600, Recruiting, Sponsor: Optimer Pharmaceuticals
Trial completion date: Jan 2014 --> Mar 2015 N=350 --> 600
- Trial primary completion date: Response to Supplement and Placebo in GERD (clinicaltrials.gov) - May 27, 2014
P=N/A, N=24, Completed, Sponsor: Beth Israel Deaconess Medical Center
N=350 --> 600 Trial primary completion date: Jan 2014 --> Apr 2014
- Trial completion: Response to Supplement and Placebo in GERD (clinicaltrials.gov) - May 27, 2014
P=N/A, N=24, Completed, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Jan 2014 --> Apr 2014 Recruiting --> Completed
- New P4 trial: Anti-peristaltic Ileo-sigmoid Anastomosis for the Treatment of Slow-transit Constipation:Therapeutic Evaluation (clinicaltrials.gov) - May 26, 2014
P4, N=50, Completed, Sponsor: Anlong Zhu
- | ondansetron / Generic mfg.
Trial initiation date: OWEP: Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=602, Recruiting, Sponsor: Sarah Williamson
Recruiting --> Completed Initiation date: Jun 2013 --> May 2014
- ondansetron / Generic mfg.
Trial completion date: OSEP: Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=868, Recruiting, Sponsor: Sarah Williamson
Initiation date: Jun 2013 --> May 2014 Trial completion date: Aug 2016 --> Dec 2016
- ondansetron / Generic mfg.
Trial completion date: OWEP: Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=602, Recruiting, Sponsor: Sarah Williamson
Trial completion date: Aug 2016 --> Dec 2016 Trial completion date: Aug 2016 --> Dec 2016
- | ondansetron / Generic mfg.
Enrollment open: OSEP: Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=868, Recruiting, Sponsor: Sarah Williamson
Trial completion date: Aug 2016 --> Dec 2016 Not yet recruiting --> Recruiting
- | ondansetron / Generic mfg.
Enrollment open: OWEP: Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=602, Recruiting, Sponsor: Sarah Williamson
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | ondansetron / Generic mfg.
Trial initiation date: OSEP: Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan (clinicaltrials.gov) - May 25, 2014
P3, N=868, Not yet recruiting, Sponsor: Sarah Williamson
Not yet recruiting --> Recruiting Initiation date: Jun 2013 --> Sep 2014
- Clinical: LACTINEDAP: Limited Abdominal CT in ED Patients With Abdominal Pain (clinicaltrials.gov) - May 22, 2014
P=N/A, N=1000, Not yet recruiting, Sponsor: Duke University
- Trial primary completion date: Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) (clinicaltrials.gov) - May 22, 2014
P1/2, N=40, Recruiting, Sponsor: Tsumura USA
Initiation date: Jun 2013 --> Sep 2014 Trial primary completion date: Aug 2014 --> Apr 2015
- Trial completion date: Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) (clinicaltrials.gov) - May 22, 2014
P1/2, N=40, Recruiting, Sponsor: Tsumura USA
Trial primary completion date: Aug 2014 --> Apr 2015 Trial completion date: Aug 2014 --> Apr 2015
- MRI: MRI and Microbiota Analysis in Constipation (clinicaltrials.gov) - May 20, 2014
P=N/A, N=24, Recruiting, Sponsor: University of Nottingham
- | New P2 trial: Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II) (clinicaltrials.gov) - May 20, 2014
P2, N=120, Not yet recruiting, Sponsor: Nutrabiotix, LLC
- ondansetron / Generic mfg., dronabinol oral / Generic mfg.
Trial completion date: Prevention of Postoperative Nausea and Vomiting in Surgical Patients (clinicaltrials.gov) - May 19, 2014
P=N/A, N=190, Active, not recruiting, Sponsor: Department of Veterans Affairs
Trial completion date: Aug 2014 --> Apr 2015 Trial completion date: Mar 2014 --> Sep 2014
- ||||| ondansetron intravenous / Generic mfg., aprepitant oral / Generic mfg.
Enrollment change: 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091) (clinicaltrials.gov) - May 19, 2014
P3, N=922, Completed, Sponsor: Merck Sharp & Dohme Corp.
Trial completion date: Mar 2014 --> Sep 2014 N=720 --> 922
- | haloperidol / Generic mfg.
New P4 trial, Surgery: Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting (clinicaltrials.gov) - May 19, 2014
P4, N=120, Completed, Sponsor: American University of Beirut Medical Center
- Clinical: Lysine Trial in Adults With Diarrhoea (clinicaltrials.gov) - May 19, 2014
P=N/A, N=440, Completed, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- Trial completion date: Internet-based Treatment of Early Childhood Fecal Incontinence (clinicaltrials.gov) - May 18, 2014
P=N/A, N=91, Completed, Sponsor: University of Virginia
N=720 --> 922 Trial completion date: Sep 2007 --> Jul 2007
- Trial completion: Internet-based Treatment of Early Childhood Fecal Incontinence (clinicaltrials.gov) - May 18, 2014
P=N/A, N=91, Completed, Sponsor: University of Virginia
Trial completion date: Sep 2007 --> Jul 2007 Active, not recruiting --> Completed
- ||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment closed: A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain (clinicaltrials.gov) - May 15, 2014
P3, N=900, Active, not recruiting, Sponsor: Purdue Pharma LP
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| oxycodone controlled release / Generic mfg., oxycodone/naloxone ER / Generic mfg.
Enrollment closed: Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain (clinicaltrials.gov) - May 15, 2014
P3, N=600, Active, not recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial primary completion date: Family Treatment for Adolescents With Anorexia Nervosa (clinicaltrials.gov) - May 15, 2014
P1, N=26, Completed, Sponsor: Towson University
Recruiting --> Active, not recruiting Trial primary completion date: May 2011 --> May 2012
- Trial completion: Family Treatment for Adolescents With Anorexia Nervosa (clinicaltrials.gov) - May 15, 2014
P1, N=26, Completed, Sponsor: Towson University
Trial primary completion date: May 2011 --> May 2012 Recruiting --> Completed
- Trial primary completion date: GPT-AN: Group Parent Training for Adolescent Eating Disorders (clinicaltrials.gov) - May 14, 2014
P=N/A, N=124, Completed, Sponsor: Duke University
Recruiting --> Completed Trial primary completion date: May 2010 --> Dec 2012
- Trial completion date: GPT-AN: Group Parent Training for Adolescent Eating Disorders (clinicaltrials.gov) - May 14, 2014
P=N/A, N=124, Completed, Sponsor: Duke University
Trial primary completion date: May 2010 --> Dec 2012 Trial completion date: Jun 2010 --> Dec 2012
- Enrollment change: GPT-AN: Group Parent Training for Adolescent Eating Disorders (clinicaltrials.gov) - May 14, 2014
P=N/A, N=124, Completed, Sponsor: Duke University
Trial completion date: Jun 2010 --> Dec 2012 N=40 --> 124
- Trial completion: GPT-AN: Group Parent Training for Adolescent Eating Disorders (clinicaltrials.gov) - May 14, 2014
P=N/A, N=124, Completed, Sponsor: Duke University
N=40 --> 124 Recruiting --> Completed
- Clinical: Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults (clinicaltrials.gov) - May 14, 2014
P=N/A, N=120, Recruiting, Sponsor: NIZO Food Research
- Trial primary completion date, Combination therapy: Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia. (clinicaltrials.gov) - May 13, 2014
P4, N=180, Completed, Sponsor: G. d'Annunzio University
Recruiting --> Completed Trial primary completion date: Oct 2009 --> Jun 2013
- Trial completion date, Combination therapy: Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia. (clinicaltrials.gov) - May 13, 2014
P4, N=180, Completed, Sponsor: G. d'Annunzio University
Trial primary completion date: Oct 2009 --> Jun 2013 Trial completion date: Jan 2010 --> Dec 2013
- Enrollment change, Combination therapy: Prophylactic Subhypnotic Propofol for Nausea and Vomiting During for Cesarean Section Under Subarachnoid Anesthesia. (clinicaltrials.gov) - May 13, 2014
P4, N=180, Completed, Sponsor: G. d'Annunzio University
Trial completion date: Jan 2010 --> Dec 2013 N=28 --> 180
- || New P2/3 trial: The Effects of a Ficus Carica in Subjects With Functional Constipation (clinicaltrials.gov) - May 13, 2014
P2/3, N=80, Recruiting, Sponsor: Chonbuk National University Hospital
- | New P4 trial: Psyllium Fiber Versus Placebo in Early Treatment After STARR for Obstructed Defecation: a Double-blind RCT (clinicaltrials.gov) - May 11, 2014
P4, N=65, Completed, Sponsor: Francesco Gabrielli
- New P2 trial: Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation (clinicaltrials.gov) - May 11, 2014
P2, N=20, Not yet recruiting, Sponsor: Centre for Addiction and Mental Health
- |||| Trial completion: Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment (clinicaltrials.gov) - May 11, 2014
P1/2, N=160, Completed, Sponsor: KGK Synergize Inc.
N=28 --> 180 Active, not recruiting --> Completed
- |||| Trial primary completion date: Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study (clinicaltrials.gov) - May 11, 2014
P3, N=1107, Completed, Sponsor: Reckitt Benckiser Healthcare (UK) Limited
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> May 2014
- Trial primary completion date: Recurrent Abdominal Pain in Children (clinicaltrials.gov) - May 11, 2014
P2, N=168, Completed, Sponsor: Baylor College of Medicine
Trial primary completion date: Jun 2014 --> May 2014 Trial primary completion date: Jul 2013 --> Dec 2013